Insulet Corporation

NASDAQ:PODD   4:00:00 PM EDT
308.00
+8.63 (+2.88%)
7:28:59 PM EDT: $307.00 -1.00 (-0.33%)
Products

FDA Says Has Identified Recall Of Insulet's Omnipod Dsah Insulin Management System's Personal Diabetes Manager (Pdm) As A Class I Recall

Published: 11/16/2022 23:44 GMT
Insulet Corporation (PODD) - :fda Says Insulet Recalls Omnipod Dsah Insulin Management System's Personal Diabetes Manager for Risk of Battery Swelling, Leakage, Or Extreme Overheating.
FDA Has Identified Recall of Insulet's Omnipod Dsah Insulin Management System's Personal Diabetes Manager (pdm) As a Class I Recall.
FDA Says There Have Been No Reports of Injuries Or Deaths Related to Recall.
FDA Says Insulet Reports 455 Complaints Involving Battery Issues, Including Three Fires Related to Recalled Product.